Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

October 01, 2004; Volume 32,Issue 10

Short Communication

  • You have access
    SIMULTANEOUS EXPRESSION OF GUINEA PIG UDP-GLUCURONOSYLTRANSFERASE 2B21 (UGT2B21) AND 2B22 IN COS-7 CELLS ENHANCES UGT2B21-CATALYZED CHLORAMPHENICOL GLUCURONIDATION
    Yuji Ishii, Aya Miyoshi, Daisuke Maji, Hideyuki Yamada and Kazuta Oguri
    Drug Metabolism and Disposition October 2004, 32 (10) 1057-1060; DOI: https://doi.org/10.1124/dmd.32.10.1057

Articles

  • You have access
    SPECIES DIFFERENTIAL STEREOSELECTIVE OXIDATION OF A METHYLSULFIDE METABOLITE OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DUAL AGONIST
    Bindhu V. Karanam, Christopher J. Welch, Vijay G. Reddy, Jennifer Chilenski, Mirlinda Biba and Stella Vincent
    Drug Metabolism and Disposition October 2004, 32 (10) 1061-1068; DOI: https://doi.org/10.1124/dmd.104.000224
  • You have access
    CONSTRUCTION OF EXPRESSION SYSTEM FOR HUMAN α1-ACID GLYCOPROTEIN IN PICHIA PASTORIS AND EVALUATION OF ITS DRUG-BINDING PROPERTIES
    Koji Nishi, Naoko Fukunaga and Masaki Otagiri
    Drug Metabolism and Disposition October 2004, 32 (10) 1069-1074; DOI: https://doi.org/10.1124/dmd.104.000513
  • You have access
    TOCOTRIENOLS ACTIVATE THE STEROID AND XENOBIOTIC RECEPTOR, SXR, AND SELECTIVELY REGULATE EXPRESSION OF ITS TARGET GENES
    Changcheng Zhou, Michelle M. Tabb, Asal Sadatrafiei, Felix Grün and Bruce Blumberg
    Drug Metabolism and Disposition October 2004, 32 (10) 1075-1082; DOI: https://doi.org/10.1124/dmd.104.000299
  • You have access
    DIFFERENCES IN THE INHIBITION OF CYTOCHROMES P450 3A4 AND 3A5 BY METABOLITE-INHIBITOR COMPLEX-FORMING DRUGS
    Donavon J. McConn, Yvonne S. Lin, Kyle Allen, Kent L. Kunze and Kenneth E. Thummel
    Drug Metabolism and Disposition October 2004, 32 (10) 1083-1091; DOI: https://doi.org/10.1124/dmd.32.10.1083
  • You have access
    EFFECTIVE DOSING REGIMEN OF 1-AMINOBENZOTRIAZOLE FOR INHIBITION OF ANTIPYRINE CLEARANCE IN GUINEA PIGS AND MICE USING SERIAL SAMPLING
    Suresh K. Balani, Ping Li, Joanne Nguyen, Kym Cardoza, Hang Zeng, Dun-Xue Mu, Jing-Tao Wu, Liang-Shang Gan and Frank W. Lee
    Drug Metabolism and Disposition October 2004, 32 (10) 1092-1095; DOI: https://doi.org/10.1124/dmd.104.000349
  • You have access
    CHARACTERIZATION OF THE RENAL TUBULAR TRANSPORT OF ZONAMPANEL, A NOVEL α-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR ANTAGONIST, BY HUMAN ORGANIC ANION TRANSPORTERS
    Tadashi Hashimoto, Shinichi Narikawa, Xiu-Lin Huang, Tsuyoshi Minematsu, Takashi Usui, Hidetaka Kamimura and Hitoshi Endou
    Drug Metabolism and Disposition October 2004, 32 (10) 1096-1102; DOI: https://doi.org/10.1124/dmd.32.10.1096
  • You have access
    IDENTIFICATION OF THE CYTOSOLIC CARBOXYLESTERASE CATALYZING THE 5′-DEOXY-5-FLUOROCYTIDINE FORMATION FROM CAPECITABINE IN HUMAN LIVER
    Toshiki Tabata, Miki Katoh, Shogo Tokudome, Miki Nakajima and Tsuyoshi Yokoi
    Drug Metabolism and Disposition October 2004, 32 (10) 1103-1110; DOI: https://doi.org/10.1124/dmd.104.000554
  • You have access
    QUANTITATIVE STRUCTURE-METABOLISM RELATIONSHIP MODELING OF METABOLIC N-DEALKYLATION REACTION RATES
    Konstantin V. Balakin, Sean Ekins, Andrey Bugrim, Yan A. Ivanenkov, Dmitry Korolev, Yuri V. Nikolsky, Andrey A. Ivashchenko, Nikolay P. Savchuk and Tatiana Nikolskaya
    Drug Metabolism and Disposition October 2004, 32 (10) 1111-1120; DOI: https://doi.org/10.1124/dmd.104.000364
  • You have access
    ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION
    Nina Isoherranen, Kent L. Kunze, Kyle E. Allen, Wendel L. Nelson and Kenneth E. Thummel
    Drug Metabolism and Disposition October 2004, 32 (10) 1121-1131; DOI: https://doi.org/10.1124/dmd.104.000315
  • You have access
    PLASMA PHARMACOKINETICS AND METABOLISM OF THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A AFTER INTRAPERITONEAL ADMINISTRATION TO MICE
    L. Sanderson, G. W. Taylor, E. O. Aboagye, J. P. Alao, J. R. Latigo, R. C. Coombes and D. M. Vigushin
    Drug Metabolism and Disposition October 2004, 32 (10) 1132-1138; DOI: https://doi.org/10.1124/dmd.104.000638
  • You have access
    ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE
    Phillip M. Gerk, Wei Li and Mary Vore
    Drug Metabolism and Disposition October 2004, 32 (10) 1139-1145; DOI: https://doi.org/10.1124/dmd.104.000372
  • You have access
    TWO MAJOR GRAPEFRUIT JUICE COMPONENTS DIFFER IN INTESTINAL CYP3A4 INHIBITION KINETIC AND BINDING PROPERTIES
    Mary F. Paine, Anne B. Criss and Paul B. Watkins
    Drug Metabolism and Disposition October 2004, 32 (10) 1146-1153; DOI: https://doi.org/10.1124/dmd.104.000547
  • You have access
    IDENTIFICATION AND METABOLISM OF A NOVEL DIHYDROHYDROXY-S-GLUTATHIONYL CONJUGATE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST, MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], IN RATS
    Vijay Bhasker G. Reddy, George A. Doss, Mellissa Creighton, Christopher J. Kochansky, Stella H. Vincent, Ronald B. Franklin and Bindhu V. Karanam
    Drug Metabolism and Disposition October 2004, 32 (10) 1154-1161; DOI: https://doi.org/10.1124/dmd.104.000240
  • You have access
    TRICLOSAN AS A SUBSTRATE AND INHIBITOR OF 3′-PHOSPHOADENOSINE 5′-PHOSPHOSULFATE-SULFOTRANSFERASE AND UDP-GLUCURONOSYL TRANSFERASE IN HUMAN LIVER FRACTIONS
    Li-Quan Wang, Charles N. Falany and Margaret O. James
    Drug Metabolism and Disposition October 2004, 32 (10) 1162-1169; DOI: https://doi.org/10.1124/dmd.104.000273
  • You have access
    IDENTIFICATION OF DI-(2-ETHYLHEXYL) PHTHALATE-INDUCED CARBOXYLESTERASE 1 IN C57BL/6 MOUSE LIVER MICROSOMES: PURIFICATION, CDNA CLONING, AND BACULOVIRUS-MEDIATED EXPRESSION
    Tomomi Furihata, Masakiyo Hosokawa, Nao Koyano, Takahiro Nakamura, Tetsuo Satoh and Kan Chiba
    Drug Metabolism and Disposition October 2004, 32 (10) 1170-1177; DOI: https://doi.org/10.1124/dmd.104.000620
  • You have access
    A CRUCIAL ROLE OF URIDINE/CYTIDINE KINASE 2 IN ANTITUMOR ACTIVITY OF 3′-ETHYNYL NUCLEOSIDES
    Daigo Murata, Yoshio Endo, Tohru Obata, Kazuki Sakamoto, Yasuhiro Syouji, Masakazu Kadohira, Akira Matsuda and Takuma Sasaki
    Drug Metabolism and Disposition October 2004, 32 (10) 1178-1182; DOI: https://doi.org/10.1124/dmd.104.000737
  • You have access
    KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4
    Konstantin V. Balakin, Sean Ekins, Andrey Bugrim, Yan A. Ivanenkov, Dmitry Korolev, Yuri V. Nikolsky, Andrey V. Skorenko, Andrey A. Ivashchenko, Nikolay P. Savchuk and Tatiana Nikolskaya
    Drug Metabolism and Disposition October 2004, 32 (10) 1183-1189; DOI: https://doi.org/10.1124/dmd.104.000356
  • You have access
    UTILITY OF WHOLE-BODY AUTORADIOLUMINOGRAPHY IN DRUG DISCOVERY FOR THE QUANTIFICATION OF TRITIUM-LABELED DRUG CANDIDATES
    Michael J. Potchoiba and Mark R. Nocerini
    Drug Metabolism and Disposition October 2004, 32 (10) 1190-1198; DOI: https://doi.org/10.1124/dmd.32.10.1190

Erratum

  • You have access
    CORRECTION TO “COMPARISON OF PREDICTION METHODS FOR IN VIVO CLEARANCE OF (S,S)-3-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE HYDROCHLORIDE, A DOPAMINE D2 RECEPTOR ANTAGONIST, IN HUMANS”
    Drug Metabolism and Disposition October 2004, 32 (10) 1199; DOI: https://doi.org/10.1124/dmd.32.10.1199
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 32 (10)
Drug Metabolism and Disposition
Vol. 32, Issue 10
1 Oct 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Short Communication
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics